Physical resolution of tubal ectopic pregnancy on ultrasound imaging following successful expectant management.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 17 11 2019
revised: 19 01 2020
accepted: 11 02 2020
pubmed: 18 5 2020
medline: 10 4 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

What is the time required for complete physical resolution of tubal ectopic pregnancies diagnosed on ultrasound imaging in women undergoing successful expectant management? A prospective observational cohort study of 177 women who had successful expectant management of tubal ectopic pregnancy, who attended a single Early Pregnancy Unit between January 2014 and December 2018. All participants were monitored until their serum beta-human chorionic gonadotrophin (beta-HCG) dropped to non-pregnant concentrations and with 2-weekly follow-up ultrasound scans until resolution of the pregnancy. A total of 112/177 (63.3%, 95% confidence interval [CI] 55.7-70.4) of tubal ectopic pregnancies were indiscernible on ultrasound 2 weeks after serum beta-HCG had returned to non-pregnant concentrations. In 8/177 (4.5%, 95% CI 2.0-8.7), physical resolution took longer than 78 days. There was a positive correlation between biochemical and physical resolution of tubal ectopic pregnancy (r = 0.21, P = 0.006). Physical resolution of tubal ectopic pregnancy is often prolonged and is positively correlated with initial and maximum beta-HCG concentrations. Results of this study indicate that beta-HCG resolution cannot be used as the end-point of expectant management of tubal ectopic pregnancy, which should be considered when counselling women and planning for future pregnancies.

Identifiants

pubmed: 32414664
pii: S1472-6483(20)30094-8
doi: 10.1016/j.rbmo.2020.02.006
pii:
doi:

Substances chimiques

Chorionic Gonadotropin, beta Subunit, Human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

880-886

Informations de copyright

Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

William Dooley (W)

Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.

Lucrezia De Braud (L)

Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.

Maria Memtsa (M)

Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.

Nikolaos Thanatsis (N)

Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.

Eric Jauniaux (E)

Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK.

Davor Jurkovic (D)

Institute for Women's Health, Faculty of Population Health Sciences, University College London, London, UK. Electronic address: d.jurkovic@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH